India Glycols Limited has announced that it has received an allocation for the supply of 18.06 crore litres of ethanol under the Ethanol Blended Petrol Programme (EBPP) for the Ethanol Supply Year (ESY) 2024-25. The total estimated value of the allocated supply stands at ₹1,264.20 crore, reinforcing the company’s role in India’s growing ethanol-blending initiative.

The share price of India Glycols has gained 32.54% in the past 1 year and the stock is down by 13% in the last 1 month. 

Who Awarded the Allocation?

The ethanol supply allocation has been awarded by key public and private sector entities, including:

• Bharat Petroleum Corporation Limited (BPCL)
• Indian Oil Corporation Limited (IOCL)
• Hindustan Petroleum Corporation Limited (HPCL)
• Reliance Industries Limited
• Nayara Energy Limited

These entities collectively form the key players in India’s fuel distribution network, working towards increasing ethanol blending in petrol to reduce the country’s dependency on crude oil imports.

Breakdown of the Allocation

The ethanol allocation for ESY 2024-25 has been distributed among different entities as follows:

 

 

Ethanol Supply from Kashipur and Gorakhpur Plants

India Glycols will fulfil the ethanol supply allocation from its plants located in Kashipur and Gorakhpur. The ethanol supplied under this contract is produced using:

• Damaged Food Grains (DFG)
• Surplus Food Corporation of India (FCI) Rice

This aligns with the government’s initiative to use alternative feedstocks for ethanol production, reducing reliance on sugarcane-derived ethanol and ensuring sustainable fuel supply.

Contract Details and Execution Timeline

The ethanol supply contract is domestic in nature, covering the period from November 1 2024 to October 31, 2025. The contract does not involve any related party transactions, and the company’s promoters do not have any direct interest in the awarding entities.

India’s Ethanol Blending Goals

The Ethanol Blended Petrol Programme (EBPP) is part of the Indian government’s broader strategy to enhance ethanol blending in petrol, aiming for 20% ethanol blending by 2025-26. This initiative contributes to:

• Reducing carbon emissions
• Enhancing energy security
• Supporting the agricultural sector through the utilisation of food grain surplus

India Glycols’ latest allocation further cements its role in this crucial national objective.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

The Indian stock market is undergoing a significant correction, which has had a substantial impact on the portfolio of the Life Insurance Corporation of India (LIC). According to reports, the market value of LIC’s holdings has declined by ₹84,247 crore in just the past one and a half months.

As of December 2024, LIC’s total holdings in listed companies were valued at ₹14.72 trillion, which has now fallen to ₹13.87 trillion as of February 18, 2025. This marks a 5.7% decline, reflecting the widespread market volatility. The study analysed 330 companies in which LIC held over a 1% stake during the October-December 2024 quarter. These companies collectively accounted for 66% of the total market capitalisation of all BSE-listed companies.

ITC, L&T, and SBI Drive Major Losses

A large portion of LIC’s portfolio decline can be attributed to the steep correction in shares of ITC, Larsen & Toubro (L&T), and State Bank of India (SBI). These stocks have witnessed a fall of over 10% in CY25, leading to a combined loss of:

• ITC: ₹11,863 crore
• L&T: ₹6,713 crore
• SBI: ₹5,647 crore

Together, these 3 stocks accounted for 29% of LIC’s total value erosion.

Market Erosion Across Key Stocks

LIC has experienced market value erosion of ₹1,000 crore or more in 26 companies, with notable declines in:

• Tata Consultancy Services (TCS)
• Jio Financial Services
• HCL Technologies
• JSW Energy
• Adani Ports and SEZ
• HDFC Bank
• IDBI Bank

Losses in these stocks range from ₹2,000 crore to ₹4,000 crore, highlighting the impact of the broader market correction.

NBFCs and Insurance Stocks Among Top Value Destroyers

The report also noted that non-banking financial companies (NBFCs) and insurance companies contributed significantly to the decline. These sectors were among the top value destroyers, leading to a combined portfolio erosion of ₹18,385 crore, making up 22% of the total loss.

Some Stocks Defied the Market Trend

Despite the overall downturn, some stocks in LIC’s portfolio managed to add value. Companies that saw an increase in LIC’s holding value by ₹1,000 crore to ₹3,000 crore included:

• Bajaj Finance
• Maruti Suzuki India
• Kotak Mahindra Bank
• Bharti Airtel
• Bajaj Finserv

These stocks defied the broader market trend, offering some resilience to LIC’s portfolio amid the correction.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

BCL Industries Limited and its subsidiary, Svaksha Distillery Limited have received 23,054 KL of extra ethanol to supply to Oil Marketing Companies (OMCs). It is made from Food Corporation of India (FCI) rice and was allocated through an OMC tender.

Order Value and Distribution

The total order is valued at ₹134.87 crore. BCL Industries will supply 14,302 KL of ethanol worth ₹83.67 crore, while Svaksha Distillery will provide 8,752 KL valued at ₹51.20 crore. This new order is in addition to the previously allocated 182,485 KL.

Government Initiatives and Ethanol Blending Program

The Indian government and OMCs are aggressively promoting ethanol blending in petrol to reduce the country’s carbon footprint and decrease dependency on crude oil imports. Ethanol derived from agricultural sources like FCI rice supports energy security and environmental sustainability. 

Company Overview and Operations

Established in 1976, BCL Industries operates in multiple sectors, including edible oils, rice milling, grain-based distilleries and real estate. The company has manufacturing plants in Punjab and West Bengal. As a major producer of grain-based ethanol in India, BCL Industries plays a significant role in the country’s ethanol supply chain.

Stock Performance

As of February 20, 2025, at 9:35 AM, with a market capitalisation of ₹11.29 billion, the shares of BCL Industries are trading at ₹38.51 per share, reflecting a surge of 5.02% from the previous day’s closing price. Over the past month, the stock has registered a loss of 25.27%. The stock’s 52-week high stands at ₹84.40 per share, while its 52-week low is ₹34.50 per share.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Medicamen Biotech Limited has announced a significant partnership under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has entered into a long-term Manufacturing & Supply Agreement with a prominent pharmaceutical distributor and marketing entity operating in the United States and Europe. This strategic collaboration aims to enhance Medicamen Biotech’s global presence and leverage its manufacturing capabilities.

Expansion into International Markets

Under the agreement, Medicamen Biotech will manufacture products for the US-based entity according to its technical specifications. The collaboration is expected to last for ten years, ensuring a stable and long-term engagement. The agreement is strictly a manufacturing and supply arrangement with no share exchange involved. Additionally, 25% of the agreement’s total consideration has been received upon signing.

This partnership aligns with Medicamen Biotech’s growth strategy, reinforcing its position in international markets, particularly in the regulated sectors of the US and Europe. The company’s USFDA-approved oncology unit will play a crucial role in executing this agreement, highlighting its commitment to high-quality manufacturing and research-driven process development.

Leveraging Advanced Manufacturing Capabilities

Medicamen Biotech will utilise its advanced manufacturing infrastructure to produce pharmaceutical products tailored to the requirements of its US partner. The agreement underscores the company’s ability to provide value-added custom manufacturing services, further strengthening its foothold in the global pharmaceutical industry. With no related party transactions involved, this deal has been structured at arm’s length, ensuring transparency and compliance with regulatory norms.

Medicamen Biotech Share Performance

As of February 20, 2025, at 11:33 AM, the shares of Medicamen Biotech are trading at ₹518.00 per share, reflecting a surge of 4.27% from the previous day’s closing price.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Mahindra Group has teamed up with Anduril Industries, a US-based firm specialising in autonomous systems, to enhance maritime and aerial security. The collaboration focuses on AI-driven Autonomous Maritime Systems, Counter-Unmanned Aerial System (CUAS) technologies, and advanced Command and Control (C2) software to strengthen regional defence capabilities.

Advancing Autonomous Defence Technologies

The partnership will develop modular Autonomous Underwater Vehicles (AUVs) designed for security, surveillance, and reconnaissance missions. These AUVs will significantly enhance underwater operational efficiency. Additionally, CUAS technologies will be developed to detect and neutralise aerial threats posed by drones, ensuring robust protection against evolving security challenges.

Smart Sensor Integration for Security

A key aspect of the collaboration is the creation of a sensor fusion platform that integrates multiple sensor technologies into an open API architecture. This approach will streamline integration processes and accelerate the deployment of advanced security solutions.

Vinod Sahay, Group Executive Board Member of Mahindra Group said, “Partnering with Anduril Industries marks a significant milestone in Mahindra Group’s commitment to developing advanced security and autonomous technologies. This collaboration combines our deep engineering expertise with Anduril’s innovative solutions to deliver cutting-edge capabilities that enhance security and address emerging threats.”

Greg Kausner, Senior Vice President of Global Defence at Anduril, stated “Global security forces face a rapidly evolving set of threats from both emerging unmanned systems and legacy manned platforms, and Autonomy is key to maintaining credible protection. Anduril is thrilled to announce our partnership with Mahindra. We believe that our two companies are well poised to bring cutting-edge autonomy-enabled capabilities to the Indian market.”

M&M Share Performance

As of February 20, 2025, at 11:55 AM, the shares of M&M are trading at ₹2,827.25 per share, reflecting a surge of 2.53% from the previous day’s closing price.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Waaree Energies has secured an order to supply 362.5 megawatt peak (MWp) of solar photovoltaic (PV) modules to a domestic company engaged in renewable power projects. The order was announced in a regulatory filing on Wednesday, though the name of the company placing the order has not been disclosed.

This is a one-time contract, and the supply of modules is scheduled to begin in fiscal 2025-26. The company confirmed that the transaction does not involve any related-party dealings, and there is no involvement from its promoters or group companies.

Manufacturing and Projects

Earlier this month, Waaree Energies began operations at its 1.40 GW solar cell manufacturing facility in Gujarat. The company has been increasing production capacity to meet the rising demand for solar modules.

In another development, Waaree Clean Energy Solutions, a wholly owned subsidiary, received a Notification of Award (NOA) from the Solar Energy Corporation of India (SECI) for setting up a 90,000 MT per annum green hydrogen production facility. This project falls under the Strategic Interventions for Green Hydrogen Transitions (SIGHT) Scheme.

Financial Performance

Waaree Energies reported a four-fold increase in net profit for the December quarter, reaching ₹492.7 crore, compared to ₹124.5 crore in the same period last year. Revenue for the quarter rose 116% year-on-year to ₹3,457.28 crore, up from ₹1,596.18 crore.

Following the announcement of the new order, Waaree Energies’ share price was at ₹2,225.00 at 9:08 AM on February 20, 2025, up ₹4.70 (0.21%) in early trade but has declined 15.55% over the past month and 4.87% over the past year.

Solar Power Growth in India

India has been increasing its focus on renewable energy, particularly solar power. Large-scale projects and manufacturing expansions have been a priority as the country works toward reducing dependence on fossil fuels. The order adds to the demand for solar modules in the Indian market.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Nava Ltd has approved a share buyback of ₹360 crore, with the company set to repurchase 72 lakh fully paid-up equity shares at ₹500 per share. The buyback represents 2.48% of the company’s total paid-up equity capital. It also accounts for 9.87% of the total paid-up equity share capital and 5.78% of free reserves, based on financials for the year ending March 31, 2024.

Record Date and Eligibility

The company has set February 28, 2025, as the record date to determine eligible shareholders. Promoters and members of the promoter group will not participate in the buyback.

Execution and Management

Anand Rathi Advisors Ltd, a SEBI-registered merchant banker, has been appointed as the manager for the buyback. The final number of shares and percentage of capital repurchased will be confirmed after the process is completed.

A Buyback Committee has been formed to look into the whole process, and the Board has the discretion to increase the buyback price while reducing the number of shares to be repurchased, provided that the total buyback amount remains unchanged.

A public announcement and letter of offer outlining the buyback process and timelines will be released in accordance with regulatory requirements.

Financial Performance

Nava Ltd reported a 24% year-on-year (YoY) decline in profit after tax (PAT) for Q3 FY25, with PAT falling to ₹353.3 crore from ₹465 crore in the same quarter of the previous year. Revenue declined 11.7% YoY, dropping from ₹995 crore to ₹878.1 crore.

Following the buyback announcement, as of February 20, 9:27 AM, Nava Ltd is trading at ₹419.75, down ₹3.50 (0.83%) for the day. Over the past month, the stock has declined 3.89%, but it remains up 62.16% over the past year.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.